Please login to the form below

Not currently logged in

United Drug buys Alliance Healthcare Information for USD 10m

Ireland-headquartered United Drug buys US pharmaceutical sales and marketing services company, Alliance Healthcare Information for over USD 10m

Ireland-headquartered United Drug (UD) has bought US pharmaceutical sales and marketing services company, Alliance Healthcare Information (AHI), for over USD 10m.

UD, which is a provider of services to healthcare manufacturers and pharmaceutical retailers in Ireland, the UK and mainland Europe, paid USD 9.5m in cash and up to USD 1m more if certain milestones are reached.

AHI provides call centre solutions to support pharmaceutical companies in the US market for their sales and marketing requirements, including medical affairs information, patient compliance support and clinical trials recruitment. The company employs 163 people.

UD's CEO, Liam FitzGerald, said: "AHI brings additional scale to our existing US contract sales outsourcing and consultancy business and will allow us to broaden our service offering and customer relationships in the US market."

Edgemont Capital Partners acted as financial advisor to AHI in the transaction.

30th September 2008


Featured jobs

Subscribe to our email news alerts


Add my company

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...